Overview
Disorder of glycosphingolipid and glycosylphosphatidylinositol (GPI) anchor glycosylation is a group of rare inherited metabolic conditions that affect how the body builds and attaches certain sugar-containing molecules to fats and proteins on cell surfaces. Glycosphingolipids are fatty molecules with sugar chains that sit on the outer surface of cells and play important roles in cell signaling, immune function, and nervous system development. GPI anchors are structures that attach specific proteins to the cell membrane, and these proteins are essential for many body functions including blood clotting, immune defense, and embryonic development. When the enzymes responsible for building these molecules do not work properly due to genetic mutations, a wide range of symptoms can occur. Because these molecules are found throughout the body, the effects can be multi-system. Common features may include intellectual disability, seizures, delayed development, distinctive facial features, skin abnormalities, and problems with blood clotting or the immune system. Some forms present at birth or in infancy, while others may appear later in childhood. Treatment is currently supportive and symptom-based, as there are no approved curative therapies for this group of disorders. Management typically involves a team of specialists who address seizures, developmental delays, and other organ-specific problems. Research is ongoing to better understand these conditions and develop targeted treatments.
Key symptoms:
Intellectual disabilitySeizures or epilepsyDelayed speech and language developmentDelayed motor milestones such as sitting and walkingDistinctive facial featuresLow muscle tone (floppiness)Skin abnormalitiesBlood clotting problemsFrequent infections due to immune system issuesHearing lossVision problemsShort stature or growth delaysAbnormalities of fingers or toesLiver or kidney problemsFeeding difficulties in infancy
Variable
Can be inherited in different ways depending on the underlying gene
Variable
Can begin at different ages, from infancy through adulthood
Treatments
No FDA-approved treatments are currently listed for Disorder of glycosphingolipid and glycosylphosphatidylinositol anchor glycosylation.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for Disorder of glycosphingolipid and glycosylphosphatidylinositol anchor glycosylation at this time.
New trials open frequently. Follow this disease to get notified.
Specialists
View all specialists →No specialists are currently listed for Disorder of glycosphingolipid and glycosylphosphatidylinositol anchor glycosylation.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to Disorder of glycosphingolipid and glycosylphosphatidylinositol anchor glycosylation.
Community
No community posts yet. Be the first to share your experience with Disorder of glycosphingolipid and glycosylphosphatidylinositol anchor glycosylation.
Start the conversation →Latest news about Disorder of glycosphingolipid and glycosylphosphatidylinositol anchor glycosylation
No recent news articles for Disorder of glycosphingolipid and glycosylphosphatidylinositol anchor glycosylation.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Questions for your doctor
Bring these to your next appointment
- Q1.What specific genetic subtype does my child have, and what does that mean for their outlook?,What seizure medications are most appropriate, and what side effects should I watch for?,Are there any clinical trials or experimental treatments available for this condition?,What developmental therapies should we start, and how often?,How will this condition affect my child's learning and what educational supports are available?,Should other family members be tested for this genetic condition?,What emergency situations should I be prepared for, and what is the action plan?
Common questions about Disorder of glycosphingolipid and glycosylphosphatidylinositol anchor glycosylation
What is Disorder of glycosphingolipid and glycosylphosphatidylinositol anchor glycosylation?
Disorder of glycosphingolipid and glycosylphosphatidylinositol (GPI) anchor glycosylation is a group of rare inherited metabolic conditions that affect how the body builds and attaches certain sugar-containing molecules to fats and proteins on cell surfaces. Glycosphingolipids are fatty molecules with sugar chains that sit on the outer surface of cells and play important roles in cell signaling, immune function, and nervous system development. GPI anchors are structures that attach specific proteins to the cell membrane, and these proteins are essential for many body functions including blood